the market?
RTI Biologics, Inc.
NASDAQ: RTIX
4.06
-0.05
(-1.22%)
| Today's Open | $4.10 |
|---|---|
| Previous Close | $4.11 |
| Daily Range | $4.03 - $4.10 |
| 52-Week Range | $3.35 - $5.11 |
| Market Cap | $228.5M |
| P/E Ratio | 29.36 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 133,310 |
| Average Daily Volume | 255,051 |
| Current FY EPS | $0.19 |
How do you think RTIX
will perform against the market?
Top RTIX Bull/Bear Pitches
ExtremesTracker (< 20)
Submitted
December 7, 2010
picks source: zzlangerhans as of 12/7/2010, these were the 5 most underperformed designated "top picks" by zz. these are the 5 picks (out 7 top picks): alny,idra,rtix,biod,bdsi No due diligence perfor … More
zzlangerhans (< 20)
Submitted
December 14, 2011
RTI is somewhat of a mystery, having more than doubled over the last 15 months despite doing nothing more than meeting expectations. I bought this stock once at 3 on the way down, held it for what see … More
News & Commentary
RTI Biologics Beats on Revenue, Matches Expectations on EPS
Just the facts, Fool.RTI Biologics® Announces Milestone in Tissue Processing: More than 5 Million Implants Sterilized wit
This Metric Suggests You're Right to Own RTI Biologics.
Don't just ask, "How much inventory?" Ask, "What kind?"Can RTI Biologics Beat These Numbers?
Checking expectationsRTI Biologics Announces Positive Clinical Results for BioCleanse®-Processed BTB Allografts Used in A
RTI Biologics Launches New Line of Biologic Implants at Americas Hernia Society’s 15th Annual Hernia
Sector
Healthcare
Industry
Healthcare Information Services
RTI Biologics, Inc. (RTIX) Description
The Company uses natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. Website: http://www.rtix.com/
CEO Rating by Glassdoor
More details for RTI Biologics Jobs
RTI Biologics reviews from employees
